tiprankstipranks
Trending News
More News >

Windtree to become sourcing partner for Evofem Biosciences

Windtree Therapeutics (WINT) announces that it has entered into a License and Supply Agreement to become the sourcing partner for Evofem Biosciences (EVFM) for one of Evofem’s FDA-approved products — PHEXXI. The product is a first-in-class hormone-free, on-demand prescription contraceptive vaginal gel that women control. PHEXXI annual revenues have grown to more than $19 million with more than 96,000 boxes of 12 pre-filled applicators sold in full year 2024.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue